Dietary Management of NIDDM

1997 ◽  
pp. 275-299
Author(s):  
Frank Q. Nuttall ◽  
Mary C. Gannon
Keyword(s):  
Dietary Management

Obesity: Behavioural Approaches to Dietary Management

1976 ◽  
Vol 2 (16) ◽  
pp. 617-618
Author(s):  
Barbara A. Brewer
Keyword(s):  
Dietary Management

Dietary management for healthier batter formulations

2021 ◽  
Author(s):  
Liew Wen Ching ◽  
Nur ‘Afifah Mat Zulkipli ◽  
Ida Idayu Muhamad ◽  
Aishah Mohd Marsin ◽  
Zulkifli Khair ◽  
...  
Keyword(s):  
Dietary Management

scholarly journals Test‐guided dietary management of eczema in children: a randomised, controlled feasibility trial (TEST)

2021 ◽  
Author(s):  
Matthew J Ridd ◽  
Douglas Webb ◽  
Kirsty Roberts ◽  
Miriam Santer ◽  
Joanne R Chalmers ◽  
...  
Keyword(s):  
Feasibility Trial ◽  
Dietary Management ◽  
Trial Test ◽  
Randomised Controlled

Lactose Intolerance and Its Dietary Management: An Update

2021 ◽  
pp. 1-11
Author(s):  
Gunjan Kumari Katoch ◽  
Neegam Nain ◽  
Sawinder Kaur ◽  
Prasad Rasane
Keyword(s):  
Lactose Intolerance ◽  
Dietary Management

scholarly journals Controversial alternative diets in the light of current dietary recommendations for overweight and obesity treatment

2017 ◽  
Vol 127 (2) ◽  
pp. 92-95
Author(s):  
Karolina Goral ◽  
Justyna Siwiela-Tomaszczyk ◽  
Renata Krzyszycha ◽  
Michał Skrzypek
Keyword(s):  
Critical Analysis ◽  
Overweight And Obesity ◽  
Dietary Management ◽  
Dietary Recommendations ◽  
Physiological Mechanisms ◽  
Metabolic Complications ◽  
Treatment Methods ◽  
Prevalence Of Obesity ◽  
Treatment Of Obesity ◽  
Epidemiological Situation

Abstract The objective of the study is a critical analysis of the selected alternative diets used in the treatment of obesity inconsistent with the recommended standards, from the perspective of clinical dieticians, based on up-to-date guidelines for dietary management of obesity. Attention was paid to the assumptions of the selected alternative diets, some physiological mechanisms related with their use, as well as the deficit of data pertaining their distant effectiveness and safety. In the context of the current epidemiological situation concerning the prevalence of obesity, it is justifiable to undertake actions aimed at the professionalization of dietary management in obesity, consisting in the application of the treatment methods based on data generated in the EBM paradigm, with a simultaneous indication and criticism of dietary pseudo-therapies with unconfirmed curative value which, in addition, do not guarantee the reduction of the risk of metabolic complications of obesity.

Role of dietary management in children with intestinal failure

2008 ◽  
Vol 40 (10) ◽  
pp. A115
Author(s):  
M.P. Cicalese ◽  
B. Aceto ◽  
A.L. Nappi ◽  
A.M. Salzano ◽  
F. Marciano ◽  
...  
Keyword(s):  
Intestinal Failure ◽  
Dietary Management

scholarly journals Adjusting diet with sapropterin in phenylketonuria: what factors should be considered?

2011 ◽  
Vol 106 (2) ◽  
pp. 175-182 ◽  
Author(s):  
Anita MacDonald ◽  
Kirsten Ahring ◽  
Katharina Dokoupil ◽  
Hulya Gokmen-Ozel ◽  
Anna Maria Lammardo ◽  
...  
Keyword(s):  
Continuing Education ◽  
Nutritional Deficiencies ◽  
Dietary Management ◽  
Clinical Protocols ◽  
Restricted Diet ◽  
Mild Form ◽  
Adequate Nutrition ◽  
Blood Phenylalanine ◽  
Overweight Or Obesity

The usual treatment for phenylketonuria (PKU) is a phenylalanine-restricted diet. Following this diet is challenging, and long-term adherence (and hence metabolic control) is commonly poor. Patients with PKU (usually, but not exclusively, with a relatively mild form of the disorder) who are responsive to treatment with pharmacological doses of tetrahydrobiopterin (BH4) have either lower concentrations of blood phenylalanine or improved dietary phenylalanine tolerance. The availability of a registered formulation of BH4 (sapropterin dihydrochloride, Kuvan®) has raised many practical issues and new questions in the dietary management of these patients. Initially, patients and carers must understand clearly the likely benefits (and limitations) of sapropterin therapy. A minority of patients who respond to sapropterin are able to discontinue the phenylalanine-restricted diet completely, while others are able to relax the diet to some extent. Care is required when altering the phenylalanine-restricted diet, as this may have unintended nutritional consequences and must be undertaken with caution. New clinical protocols are required for managing any dietary change while maintaining control of blood phenylalanine, ensuring adequate nutrition and preventing nutritional deficiencies, overweight or obesity. An accurate initial evaluation of pre-sapropterin phenylalanine tolerance is essential, and the desired outcome from treatment with sapropterin (e.g. reduction in blood phenylalanine or relaxation in diet) must also be understood by the patient and carers from the outset. Continuing education and support will be required thereafter, with further adjustment of diet and sapropterin dosage as a young patient grows.

Sign in / Sign up

Export Citation Format

Share Document